Purchase Order 75N93025P00153
Award Date 12/9/24
Potential Completion Date 2/28/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $172,599.60 firm-fixed-price purchase order to Infinity Biologix LLC, doing business as Sampled Division, for whole genome sequencing services. This contract does not have a socioeconomic set-aside. Infinity Biologix is a leading provider of genomic analysis, sequencing, and biorepository services that has supported various federal agencies, including the Department of Veterans Affairs, Department of Agriculture, and...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $49,946.10 firm-fixed-price purchase order contract for antibody expression services to Biointron Biological USA Inc., a small disadvantaged business. The contract, which has no set-aside designation, has an ultimate completion date of July 11, 2025. The award was made on July 12, 2024. NIAID is responsible for conducting and supporting research to understand, treat, and prevent infectious and...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), awarded a $20,000 firm-fixed-price purchase order contract to Bioinforx, Inc., a for-profit small disadvantaged business. The contract is for Bioinforx to provide a laboratory information management system (LIMS) with the capacity to support over 20,000 animal cages. The contract has an ultimate completion date of October 31, 2025. Bioinforx has...
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded a $33,273,522 cost-plus-fixed-fee definitive contract to Anivive Lifesciences Inc., a self-certified small disadvantaged business, to develop vaccine candidates for biodefense and emerging infectious diseases. This contract, awarded on June 7, 2024, is part of NIAID's Broad Agency Announcement (BAA) research program and has a completion date of June 1, 2026. The contract...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $6,452,710.88 delivery order against the NIAID Preclinical Models of Infectious Diseases 2017-2024 master IDIQ to the American Foundation For Biological Research, doing business as Biomedical Research Institute, for maintenance, development and production of schistosomiasis parasites, and reagents with a completion date of July 7, 2023. The contract has no...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $11,130 firm fixed price purchase order to Mission Bio, Inc. for biological supplies and reagent kits. The place of performance will be Mission Bio's location in South San Francisco, California. The period of performance is from August 28, 2023 through October 15, 2023. As the National Institute of Allergy and Infectious Diseases conducts research on...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $300,000 firm fixed price definitive contract to Nference Inc., a for-profit organization located in Cambridge, Massachusetts, to deliver on SBIR Topic 111 with a completion date of September 15, 2023. No set-aside designation was used for this award. The contract will support the National Institute of Allergy and Infectious Diseases' mission to conduct and...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services (HHS), to the Seattle Biomedical Research Institute (doing business as the Center for Infectious Disease Research), a non-profit organization. The $13,104 firm-fixed-price purchase order is for IT access and collaboration services. The award does not have a set-aside designation. The contract supports NIAID's mission of...
- This is a federal purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the Institut National De Recherche Biomedicale, a non-profit organization based in the Democratic Republic of the Congo. The contract has a ceiling value of $149,950.00 and a completion date of September 15, 2017. The contract is for the provision of goods and services related to entomological monitoring, vector...
- This federal contract award, valued at $4,008,921.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract supports the Emerging Infectious Diseases Research PREVAIL I, III, V, and PREVAC Mali programs, which focus on research related to infectious diseases. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing...